Vuno Inc. (KOSDAQ: 338220)

Market Cap	331.93B
Revenue (ttm)	23.72B
Net Income (ttm)	-16.40B
Shares Out	13.89M
EPS (ttm)	-1,222.64
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	214,015
Open	25,100
Previous Close	25,100
Day's Range	23,800 - 25,250
52-Week Range	21,700 - 45,350
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 5, 2025

About Vuno Inc.

Vuno Inc. operates as a medical artificial intelligence (AI) solution development company. The company provides medical AI solutions for analyzing various medical data and assisting in disease diagnosis. Its products include BoneAge, an AI diagnostic software for bone age assessment; DeepBrain, a brain parcellation for the quantitative analysis of neurodegenerative diseases and other neurological disorders; chest X-ray, a diagnostic support system for abnormalities in chest x-ray; fundus AI, an AI-based screening solution for various abnormalit...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2014
• Employees: 148
• Stock Exchange: KOSDAQ
• Ticker Symbol: 338220

Financial Performance

In 2023, Vuno Inc.'s revenue was 13.28 billion, an increase of 60.44% compared to the previous year's 8.27 billion. Losses were -15.63 billion, -0.22% less than in 2022.